System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Geoffrey Strobbe is an expert in Pharmacy at Centre Oscar Lambret (France). Geoffrey Strobbe has authored 13 publications, the most recent in 2025. SLR score: 35 (community average: 125). How the SLR is computed.

LeadR Profile

Geoffrey Strobbe Centre Oscar Lambret France
35 ScienceLeadR Reputation 35

Unlock

Register Login
Network Map

Pharmacy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2025
Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 13

Citations

Citations: 16 1st author: 7 Last author: 1 Unique author: 0

Main journals

J Oncol Pharm Pract 4
Bull Cancer 2
˜Le œpharmacien clinicien 2
Acta Oncol 1
Eur J Clin Pharmacol 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Development and evaluation of a new protocol for the management of immediate hypersensitivity reactions in an oncology outpatient department.
PMID 40628554 — hypersensitivity, neoplasms, work, therapeutics, outpatients, hypersensitivity, immediate		Bull Cancer20250
Securing the oral and enteral oncopediatric chemotherapy process in pediatric oncology: Introduction of the ENFit™ standard in a controlled-atmosphere area and implementation of a dispensing service of medications to outpatients circuit with advice on proper use.
PMID 38613327 — patient care, medical oncology, syringes, pediatrics, pharmacy, drug therapy, caregivers, atmosphere, outpatients, chemotherapy		J Oncol Pharm Pract20240
Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy.
PMID 39223928 — pharmaceutical services, cholestasis, powders, pharmaceutical preparations, neoplasms, dietary supplements, pharmacy, drug therapy, liver, neoplasm metastasis, agaricales, therapeutics, medical oncology, colorectal neoplasms, complementary therapies, chemotherapy		J Oncol Pharm Pract20241
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
PMID 37438439 — ranitidine, injections, histamine, incidence, paclitaxel, hypersensitivity, premedication, drug therapy, pharmacology		Eur J Clin Pharmacol20233
5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study)
OpenAlex W4360614898 — injections, histamine, incidence, paclitaxel, hypersensitivity, adrenal cortex hormones, premedication		Section 5: Patient safety and quality assurance20230

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS